• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用蒙特卡罗方法生成类药物分子群体对被动肠膜通透性进行的理论研究。

Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.

作者信息

Sugano Kiyohiko

机构信息

Global Research & Development, Sandwich Laboratories, Research Formulation, Pfizer Inc., CT13 9NJ Sandwich, Kent, UK.

出版信息

Int J Pharm. 2009 May 21;373(1-2):55-61. doi: 10.1016/j.ijpharm.2009.02.002. Epub 2009 Feb 12.

DOI:10.1016/j.ijpharm.2009.02.002
PMID:19429288
Abstract

The purpose of the present study was to investigate the effect of the physiological and morphological differences between in vivo and in vitro systems on the estimation of in vivo effective intestinal membrane permeability (P(eff)) from in vitro permeability data (P(ivt,app)). Five hundred virtual drug-like compounds were generated using Monte Carlo method based on the distribution of octanol water partition coefficient, molecular weight, and pK(a). In vivo and in vitro membrane permeability was theoretically calculated from these parameters considering the transcellular, paracellular and unstirred water layer (UWL) permeation. More than 50% of drug-like compounds showed high P(eff) values. When the same pH value was used for in vivo and in vitro, the scattering of the P(ivt,app)-P(eff) plot was small, whereas it was large when different pH values were used. However, the extent of discrepancy depended on the physicochemical properties and permeation characteristics of a drug. When the pH effect was directly corrected on the P(eff) value, paracellular and UWL permeability was inappropriately corrected since the pH partition theory is only applicable for transcellular permeation. In vivo species differences of P(eff) and the fraction of a dose absorbed (Fa%) was also investigated for humans, rats and dogs. In conclusion, P(eff) estimation from in vitro data should be based on the theoretical method rather than simple linear regression.

摘要

本研究的目的是调查体内和体外系统之间的生理和形态学差异对根据体外通透性数据(P(ivt,app))估算体内有效肠膜通透性(P(eff))的影响。基于辛醇水分配系数、分子量和pKa的分布,采用蒙特卡罗方法生成了500种虚拟类药物化合物。考虑跨细胞、细胞旁和未搅动水层(UWL)渗透,从这些参数理论计算体内和体外膜通透性。超过50%的类药物化合物显示出高P(eff)值。当体内和体外使用相同的pH值时,P(ivt,app)-P(eff)图的离散度较小,而当使用不同的pH值时,离散度较大。然而,差异程度取决于药物的理化性质和渗透特性。当直接在P(eff)值上校正pH效应时,由于pH分配理论仅适用于跨细胞渗透,细胞旁和UWL通透性被不恰当地校正。还研究了人类、大鼠和狗的P(eff)体内种属差异以及吸收剂量分数(Fa%)。总之,根据体外数据估算P(eff)应基于理论方法而非简单的线性回归。

相似文献

1
Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.使用蒙特卡罗方法生成类药物分子群体对被动肠膜通透性进行的理论研究。
Int J Pharm. 2009 May 21;373(1-2):55-61. doi: 10.1016/j.ijpharm.2009.02.002. Epub 2009 Feb 12.
2
Prediction of oral drug absorption in humans by theoretical passive absorption model.通过理论被动吸收模型预测人体口服药物的吸收情况。
Int J Pharm. 2005 Apr 11;293(1-2):183-92. doi: 10.1016/j.ijpharm.2005.01.005.
3
Estimation of effective intestinal membrane permeability considering bile micelle solubilisation.考虑胆汁微团增溶作用的有效肠膜通透性估计
Int J Pharm. 2009 Feb 23;368(1-2):116-22. doi: 10.1016/j.ijpharm.2008.10.001. Epub 2008 Oct 15.
4
Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.颗粒漂流效应对肠道非搅动水层有效厚度的可能降低作用。
Int J Pharm. 2010 Mar 15;387(1-2):103-9. doi: 10.1016/j.ijpharm.2009.12.014. Epub 2009 Dec 16.
5
In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.在药物产品开发中的胃肠道药物吸收的计算预测:机制吸收模型 GI-Sim 的应用。
Eur J Pharm Sci. 2013 Jul 16;49(4):679-98. doi: 10.1016/j.ejps.2013.05.019. Epub 2013 May 29.
6
In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.基于 PAMPA 渗透率的 QSAR 分析对人类口服吸收的体内预测。
Chem Biodivers. 2009 Nov;6(11):1845-66. doi: 10.1002/cbdv.200900112.
7
Exploring the role of different drug transport routes in permeability screening.探索不同药物转运途径在渗透性筛选中的作用。
J Med Chem. 2005 Jan 27;48(2):604-13. doi: 10.1021/jm049711o.
8
A physiological model for the estimation of the fraction dose absorbed in humans.一种用于估算人体吸收剂量分数的生理模型。
J Med Chem. 2004 Jul 29;47(16):4022-31. doi: 10.1021/jm030999b.
9
Intestinal permeability and its relevance for absorption and elimination.肠道通透性及其与吸收和排泄的相关性。
Xenobiotica. 2007 Oct-Nov;37(10-11):1015-51. doi: 10.1080/00498250701704819.
10
QSAR study on permeability of hydrophobic compounds with artificial membranes.疏水性化合物通过人工膜的渗透性的定量构效关系研究。
Bioorg Med Chem. 2007 Jun 1;15(11):3756-67. doi: 10.1016/j.bmc.2007.03.040. Epub 2007 Mar 16.

引用本文的文献

1
Inhibition of Neural Crest Cell Migration by Strobilurin Fungicides and Other Mitochondrial Toxicants.嘧菌酯类杀菌剂及其他线粒体毒物对神经嵴细胞迁移的抑制作用
Cells. 2024 Dec 12;13(24):2057. doi: 10.3390/cells13242057.
2
A guide to developing population files for physiologically-based pharmacokinetic modeling in the Simcyp Simulator.用于 Simcyp 模拟器中基于生理的药代动力学建模的群体文件开发指南。
CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1429-1447. doi: 10.1002/psp4.13202. Epub 2024 Jul 18.
3
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profile.
伊维菌素的 PBPK 建模——考虑开发替代途径以优化其安全性特征的目的。
CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):598-609. doi: 10.1002/psp4.12950. Epub 2023 Mar 15.
4
Integrating In Vitro Biopharmaceutics into Physiologically Based Biopharmaceutic Model (PBBM) to Predict Food Effect of BCS IV Zwitterionic Drug (GSK3640254).将体外生物药剂学整合到基于生理的生物药剂学模型(PBBM)中,以预测BCS IV类两性离子药物(GSK3640254)的食物效应。
Pharmaceutics. 2023 Feb 3;15(2):521. doi: 10.3390/pharmaceutics15020521.
5
A Mechanistic Absorption and Disposition Model of Ritonavir to Predict Exposure and Drug-Drug Interaction Potential of CYP3A4/5 and CYP2D6 Substrates.利托那韦的机制吸收和处置模型预测 CYP3A4/5 和 CYP2D6 底物的暴露和药物相互作用潜力。
Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):483-495. doi: 10.1007/s13318-022-00765-w. Epub 2022 Apr 29.
6
Lost in modelling and simulation?迷失在建模与仿真中?
ADMET DMPK. 2021 Mar 22;9(2):75-109. doi: 10.5599/admet.923. eCollection 2021.
7
Prediction of Oral Drug Absorption in Rats from In Vitro Data.基于体外数据预测大鼠口服药物的吸收情况。
Pharm Res. 2023 Feb;40(2):359-373. doi: 10.1007/s11095-022-03173-6. Epub 2022 Feb 15.
8
Physiologically Based Biopharmaceutics Modeling of Regional and Colon Absorption in Dogs.犬类局部及结肠吸收的基于生理学的生物药剂学建模
Mol Pharm. 2021 Apr 5;18(4):1699-1710. doi: 10.1021/acs.molpharmaceut.0c01201. Epub 2021 Mar 15.
9
Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus.体外生理双相溶解装置中溶质传递的机理分析。
Biopharm Drug Dispos. 2012 Oct;33(7):378-402. doi: 10.1002/bdd.1803. Epub 2012 Sep 4.
10
Crystalline nanosuspensions as potential toxicology and clinical oral formulations for BCS II/IV compounds.晶型纳米混悬剂作为 BCS II/IV 化合物潜在的毒理学和临床口腔制剂。
AAPS J. 2012 Dec;14(4):677-87. doi: 10.1208/s12248-012-9383-0. Epub 2012 Jun 27.